Evidence map›Paper›PMID 42137472›Full record

ArticleRSC advances2026

Discovery of

Ahmed A Al-Karmalawy, Mohamed Ibrahim Attia, Radwan Alnajjar, Riham A El-Shiekh, Arwa Omar Al Khatib, Tarek A Yousef, Essam Abdel-Sattar

Abstract read
In one paragraph

Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ahmed A Al-KarmalawyDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Horus University-Egypt New Damietta 34518 Egypt akarmalawy@horus.edu.eg.ORCID https://orcid.org/0000-0002-8173-6073
Mohamed Ibrahim AttiaCollege of Science, Chemistry Department, Imam Mohammad Ibn Saud Islamic University (IMSIU) Riyadh 11623 Saudi Arabia tayousef@imamu.edu.sa.
Radwan AlnajjarDepartment of Chemistry, Faculty of Science, University of Benghazi Benghazi Libya.ORCID https://orcid.org/0000-0003-1869-9596
Riham A El-ShiekhPharmacognosy Department, Faculty of Pharmacy, Cairo University Kasr El-Aini Street 11562 Cairo Egypt.ORCID https://orcid.org/0000-0002-3179-3352
Arwa Omar Al KhatibFaculty of Pharmacy, Al-Ahliyya Amman University Amman Jordan.
Tarek A YousefCollege of Science, Chemistry Department, Imam Mohammad Ibn Saud Islamic University (IMSIU) Riyadh 11623 Saudi Arabia tayousef@imamu.edu.sa.
Essam Abdel-SattarPharmacognosy Department, Faculty of Pharmacy, Cairo University Kasr El-Aini Street 11562 Cairo Egypt.ORCID https://orcid.org/0000-0002-0617-1420

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is the fourth leading cause of death among elderly people worldwide. It has a complex pathogenesis, making multitarget-directed ligands (MTDLs) a key therapeutic strategy. This study evaluated pregnane glycosides isolated from

Identifiers

PMID42137472
PMCPMC13169111

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.